US toughens rules for clinical-trial transparency
By Sara Reardon,
Nature News
| 09. 16. 2016
The disappointing results of clinical trials will no longer be able to languish unpublished, thanks to rules released on 16 September by the US Department of Health and Human Services (HHS) and the US National Institutes of Health (NIH).
The long-awaited changes to the HHS clinical-trial disclosure laws requires, for the first time, that researchers report the design and results of all clinical trials and empowers the government to enforce penalties for those that do not comply. The NIH rules apply only to work done through agency grants, and include stricter reporting requirements for phase I trials. If institutions don’t follow the rules, the NIH could withdraw their funding.
“I think a lot of major universities just miss the point that if you do an experiment on a person and get consent, you really have the obligation to make the results known,” says Robert Califf, head of the US Food and Drug Administration (FDA). “This is fundamentally an ethical issue.”
Both sets of rules are intended to crack down on the large number of clinical trials that are conducted but...
Related Articles
By Caroline Kitchener, The New York Times | 08.21.2025
Less than two weeks after an Alabama Supreme Court decision upended in vitro fertilization in the state and prompted a national backlash, over 100 conservative congressional staff members and I.V.F. skeptics crammed into a meeting room a few blocks from...
By Carter Sherman, The Guardian | 08.23.2025
For Erica L and her husband, in-vitro fertilization was the “nuclear option”.
After two years of trying to conceive, Erica and her husband had no idea why they could not have a baby. Doctors said only that they had “unexplained...
By Riley Beggin and Jeff Stein, The Washington Post | 08.03.2025
The White House does not plan to require health insurers to provide coverage for in vitro fertilization services, two people with knowledge of internal discussions said, even though the idea was one of President Donald Trump’s key campaign pledges.
Last...
By Sayantani DasGupta, MedPage Today | 08.05.2025
It's just a jeans ad.
It's not that deep.
It's just social media outrage.
Should physicians care about the recent American Eagle "Sydney Sweeney Has Good Genes Jeans" controversy? What, if anything, does the provocative campaign have to...
